Dataset Information

HBV genotypic variability in Cuba.

ABSTRACT: The genetic diversity of HBV in human population is often a reflection of its genetic admixture. The aim of this study was to explore the genotypic diversity of HBV in Cuba. The S genomic region of Cuban HBV isolates was sequenced and for selected isolates the complete genome or precore-core sequence was analyzed. The most frequent genotype was A (167/250, 67%), mainly A2 (149, 60%) but also A1 and one A4. A total of 77 isolates were classified as genotype D (31%), with co-circulation of several subgenotypes (56 D4, 2 D1, 5 D2, 7 D3/6 and 7 D7). Three isolates belonged to genotype E, two to H and one to B3. Complete genome sequence analysis of selected isolates confirmed the phylogenetic analysis performed with the S region. Mutations or polymorphisms in precore region were more common among genotype D compared to genotype A isolates. The HBV genotypic distribution in this Caribbean island correlates with the Y lineage genetic background of the population, where a European and African origin prevails. HBV genotypes E, B3 and H isolates might represent more recent introductions.

SUBMITTER: Loureiro CL

PROVIDER: S-EPMC4351247 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

HBV genotypic variability in Cuba.

Loureiro Carmen L CL Aguilar Julio C JC Aguiar Jorge J Muzio Verena V Pentón Eduardo E Garcia Daymir D Guillen Gerardo G Pujol Flor H FH

PloS one 20150305 3

The genetic diversity of HBV in human population is often a reflection of its genetic admixture. The aim of this study was to explore the genotypic diversity of HBV in Cuba. The S genomic region of Cuban HBV isolates was sequenced and for selected isolates the complete genome or precore-core sequence was analyzed. The most frequent genotype was A (167/250, 67%), mainly A2 (149, 60%) but also A1 and one A4. A total of 77 isolates were classified as genotype D (31%), with co-circulation of several ...[more]

PMID: 25742179

Similar Datasets

Project description:The development of cassava genotypes with root system traits that increase soil resource acquisition could increase yields on infertile soils but there are relatively few work that has quantified cassava root system architecture (RSA). We used an easily adaptable and inexpensive protocol to: (i) measure genotypic variation for RSA and shoot traits of a range of cassava genotypes; and (ii) identify candidate variables that contribute the largest share of variance. Cassava genotypes were grown in soil-filled pots, maintained at 70% field capacity. Shoot and RSA traits were measured on plants grown up to 30, 45 and 60 days. Multivariate analysis was used to determine major traits contributing to variation. The study showed that cassava roots are adventitious in origin consisting of a main root axis and orders of lateral roots, and therefore the historically used term "fibrous roots" are redundant currently not contributing to clarity. There were significant differences (P < 0.05) for traits evaluated. The highest relative root growth rate occurred over the first 30 days and ranged from 0.39 to 0.48 cm day-1. Root fresh weight was significantly correlated with other traits, including root length (r = 0.79), leaf area (r = 0.72), number of lower nodal roots (r = 0.60), indicating that direct selection based on these traits might be sufficient to improve root biomass. Up to the first six principal components explained over 80% of the total variation among the genotypes for the traits measured at 30, 45 and 60 days. Leaf area, root diameter and branching density-related traits were the most important traits contributing to variation. Selection of cassava genotypes based on shoot and root biomass, root diameter and branching density at juvenile growth stage could be successful predictors of nutrient and water-use efficiency in the field. Further studies are required to relate studied juvenile cassava root traits with the performance of field-grown-mature plant with regard to drought, nutrient-use efficiency and yield.

Project description:We recently reported complex hepatitis B virus (HBV) drug resistant and concomitant vaccine escape hepatitis B surface antigen (HBsAg) variants during human immunodeficiency virus (HIV) co-infection and antiretroviral therapy (ART) exposure in Ethiopia. As a continuation of this report using the HBV positive sera from the same study participants, the current study further analyzed the HBV basal core promoter (BCP)/precore (PC) genes variability in patients with HBV drug resistance (at tyrosine-methionine-aspartate-aspartate (YMDD) reverse transcriptase (RT) motifs) and HIV co-infection in comparison with HBV mono-infected counterparts with no HBV drug resistant gene variants.A total of 143 participants of HBV-HIV co-infected (n = 48), HBV mono-infected blood donors (n = 43) and chronic liver disease (CLD) patients (n = 52) were included in the study. The BCP/PC genome regions responsible for HBeAg expression from the EcoRI site (nucleotides 1653-1959) were sequenced and analyzed for the BCP/PC mutant variants.Among the major mutant variants detected, double BCP mutations (A1762T/G1764A) (25.9%), Kozak sequences mutations (nt1809-1812) (51.7%) and the classical PC mutations such as A1814C/C1816T (15.4%), G1896A (25.2%) and G1862T (44.8%) were predominant mutant variants. The prevalence of the double BCP mutations was significantly lower in HIV co-infected patients (8.3%) compared with HBV mono-infected blood donors (32.6%) and CLD patients (36.5%). However, the Kozak sequences BCP mutations and the majority of PC mutations showed no significant differences among the study groups. Moreover, except for the overall BCP/PC mutant variants, co-prevalence rates of each major BCP/PC mutations and YMDDRT motif associated lamivudine (3TC)/entecavir (ETV) resistance mutations showed no significant differences when compared with the rates of BCP/PC mutations without YMDD RT motif drug resistance gene mutations. Unlike HIV co-infected group, no similar comparison made among HBV mono-infected blood donors and CLD patients since none of them developed the YMDD RT motif associated 3TC/ETV resistance mutations. However, HBV mono-infected blood donors and CLD patients who had no any drug resistance gene variants developed comparable G1862T (60.6% vs. 65.1%) and G1896A (24.2% vs. 11.6%) PC gene mutations.No correlation observed between the BCP/PC genome variability and the YMDD RT motif associated HBV drug resistance gene variants during HIV co-infection. Nevertheless, irrespective of HIV co-infection status, the higher records of the BCP/PC gene variability in this study setting indicate a high risk of potential HBeAg negative chronic HBV infection in Northwest Ethiopia.

Dataset Information

HBV genotypic variability in Cuba.

Publications

HBV genotypic variability in Cuba.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure